| Name | Title | Contact Details |
|---|
PriceSpective is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avance Care is a primary care provider with locations in Charlotte and Raleigh Durham. They offer same day/next day appointments for pediatrics, teens, and adults, and provide comprehensive care for physical, mental, and emotional health.
Allphase Clinical Research Services Inc. is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SolutionHealth is a new, regional healthcare system comprised of Elliot Health System and Southern New Hampshire Health. SolutionHealth allows both Elliot Health System and Southern New Hampshire Health to be even better together by pursuing actionable strategies to improve the health of our communities with collaborations that improve access to high quality, high value care delivered locally.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.